Outcomes of the 2020 ISCC Meeting

The 2020 ISCC was a working meeting that focused on short-term and long-term cancer control priorities; challenges and opportunities during the COVID-19 pandemic; synergies and gaps in the implementation science space across National Cancer Institute funded initiatives; and discussion on infrastructures for cross collaboration.

Read a summary of the ISCC Meeting (PDF, 1.4 MB)

Welcome and Overview of ISCC 2020

The welcome address by David Chambers began with a brief history of IS at NCI and highlighted key efforts and activities completed in the IS field since the first ISCC in 2019. He recognized the importance of a field-wide approach to making IS a reality, emphasizing the significance of ongoing mentoring and technical assistance; capacity building in community and clinical settings; and designing the next generation of studies that are impactful, rigorous, relevant, and ambitious.

Bryan Weiner gave an overview of the 2020 ISCC attendees, outlined the meeting objectives, and walked through the meeting agenda. Over the course of two days, attendees were given the opportunity to participate in two panel discussions and a town hall meeting, and dive into deeper conversation in two of the eight action groups.

Speakers:

  • David Chambers — National Cancer Institute
  • Bryan Weiner — University of Washington

Synergies, Gaps and Opportunities in Implementation Science (IS)

The Day 1 panel looked at the synergies, gaps, and opportunities for involvement in IS and cancer control through a dialogue with representatives from various federally funded initiatives that are either focused on IS and cancer control or may have a significant IS component. Some of these are NCI Cancer Moonshot-funded, and some predate the Cancer Moonshot.

Speakers:

  • Moderator: Cam Escoffery — Emory University
  • Mark Doescher — Oklahoma University
    American Indian Collaboration - Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)
  • Kristie Foley — Wake Forest University
    Implementation Science Centers in Cancer Control (ISC3) and Smoking Cessation at Lung Examination: The SCALE collaboration
  • Kimberly Kaphingst — The University of Utah
    Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes
  • Katharine Rendle — University of Pennsylvania Perelman School of Medicine
    Population-based Research to Optimize the Screening PRocess (PROSPR)
  • Betsy Rolland — University of Wisconsin, Madison
    Cancer Center Cessation Initiative (C3I)
  • J.D. Smith — University of Utah
    Improving the Management of symPtoms during And following Cancer Treatment (IMPACT)
  • Sujha Subramanian — RTI
    Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)
  • Stephanie Wheeler — University of North Carolina
    Cancer Prevention and Control Research Network (CPCRN)

Virtual Report Out from Day 1 Action Groups

The IS action groups gave meeting attendees the opportunity to participate in deep conversations with their IS colleagues about two of eight IS priority subjects. The action groups met to brainstorm how to move the topic forward by developing “public goods” to benefit the field, identify concrete next steps, and identify volunteers to lead/co-lead/collaborate on specific actionable ideas. These meetings served as a launching pad for future cross-field collaboration.

Practitioner Perspectives: Considering COVID-19 and IS in Cancer Control

The Day 2 panel discussion brought together practitioners in cancer control to discuss how COVID-19 and the related mitigation responses have impacted cancer control efforts among communities and in clinical settings. Additionally, the panelists discussed the role that IS could play in addressing the cancer control priorities of practices in cancer care delivery organizations and addressed the unique issues that have arisen in the midst of the pandemic.

Speakers:

  • Moderator: Rachel Issaka — University of Washington
  • Broderick Crawford — NBC Community Development Organization
  • Jessica Palakshappa — Wake Forest University
  • Rajiv Panikkar — Geisinger
  • Samuel Takvorian — University of Pennsylvania
  • Vicky Young — South Carolina Primary Care Association

Town Hall: Setting the Stage for IS in Cancer Control in the Coming Year

Led by David Chambers, meeting participants were guided through a series of questions to receive feedback on their experience over the two-day meeting. With the help of Mentimeter, Chambers was able to collect and audibly review attendee responses to the questions. The questions covered topics including main takeaways, the IS community, and advice for the consortium moving forward.

Speakers:

  • David Chambers — National Cancer Institute

Steering Committee

Prajakta Adsul, MBBS, MPH, PhD

University of New Mexico Comprehensive Cancer Center

Sarah Bruce Bernal, MA

National Cancer Institute

Heather Brandt, PhD, CHES

St. Jude Children’s Research Hospital

David Chambers, DPhil

National Cancer Institute

Mindy Clyne, MHS, CGC

National Cancer Institute

Maria Fernandez, PhD

UT Health Science Center, Houston

Kristie Long Foley, PhD

Wake Forest School of Medicine

Simon Craddock Lee, PhD MPH

UT Southwestern Simmons Comprehensive Cancer Center

Hope Krebill, MSW, BSN, RN

University of Kansas Medical Center

Brian Mittman, PhD

Kaiser Permanente Southern California

Wynne Norton, PhD

National Cancer Institute

April Oh, PhD, MPH

National Cancer Institute

Alanna Kulchak Rahm, PhD, MS, LGC

Geisinger

Donna Shelley, MD, MPH

NYU Langone Health

Rachel Shelton, ScD, MPH

Columbia University, Mailman School of Public Health

Cynthia Vinson, PhD, MPA

National Cancer Institute

Bryan Weiner, PhD

University of Washington

Stephanie Wheeler, PhD, MPH

University of North Carolina, Chapel Hill